Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Exp Eye Res. 2009 Jun 12;89(4):522–531. doi: 10.1016/j.exer.2009.05.012

Figure 4.

Figure 4

Enhancement of CXCL12 expression occurs in the eye of DO11.10 mice at 24 hours after OVA challenge. OVA or PBS as a control vehicle was administered intravitreally (n=2). Twenty-four hours later, the iris was dissected and fixed in paraformaldehyde. Immunohistochemical analysis was performed to detect CXCL12 protein expression in the eye. Note: Augmented CXCL12 staining detected within ocular vessels of OVA-treated eye.